glp 1 progress GLP-1, GLP1/GIP, and Triple G: Advanced Weight Loss Injections at LIVation GLP-1 Weight Loss Tracker Progress

SURMOUNT-1 Trial (New England Journal of Medicine, 2022) Randomized, double-blind, placebo-controlled 2,539 participants 72 weeks NCT04184622 Tirzepatide 5 mg -16.0% Mean body weight reduction Tirzepatide 10 mg -21.4% Mean body weight reduction Tirzepatide 15 mg -22.5% Mean body weight reduction Placebo group: -2.4% All results statistically significant (p 27 with Comorbidities Overweight or obese patients (Indian cutoff BMI 23+ with risk factors) seeking significant, sustained weight loss

The result for many is a gradual, sustained drop in weight

These multiple functions of FLNA derive from its unique structure, schematically represented in Figure 2

The GLOW Stack $360 (No labs required) A rejuvenation powerhouse, the GLOW Stack combines GHK-Cu, TB-500, and BPC-157

The downside risks become more pronounced any higher we go from here without significant earnings beats and raises